Participants 65 107 5
patients receiving intravenous antibiotics
Participants 404 465 6
patient group receiving prolonged courses of i.v. antibiotics
Participants 625 694 6
Patients with cystic fibrosis receiving intermittent i.v. antibiotics
Participants 1611 1653 4
patients requiring longer term i.v. access
